Boehringer Ingelheim Venture Fund and Hong Kong Science Park Launch Co-Incubation Plan
Germany-based pharmaceutical giant Boehringer Ingelheim’s venture fund (BIVF) and China-based Hong Kong Science & Technology...
Innovent Biologics’ Tyvyt Approved for First-Line Esophageal Squamous Cell Carcinoma
The National Medical Products Administration (NMPA) website indicates that China-based Innovent Biologics, Inc. (HKG: 1801)...
China’s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...
Shenzhen AXBio Closes USD 100 Million Series B Round for Sequencing Tech Expansion
Shenzhen-based fourth-generation sequencing company Anxuyuan Biotechnology (shenzhen) Company Limited (AXBio) has reportedly secured close to...
Boston Scientific Launches Expect Airway Ultrasound Needle in China for Lung Cancer Diagnosis
US-based Boston Scientific Corporation (NYSE: BSX) has announced the official market launch of its Expect...
Iomics Biosciences Secures RMB 100 Million for Proteomics and Spatialomics Expansion
Beijing-based Iomics Biosciences Co., Ltd, a developer of gene sequencing and diagnostic equipment, has reportedly...
InnoCare and Keymed Biosciences’ CCR8-Targeted mAb CM369 Accepted by NMPA
China-based InnoCare (HKG: 9969) and Keymed Biosciences Inc. (HKG: 2162) announced that an Investigational New...
CDE Releases 58th and 59th Batches of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 58th and 59th batches of chemical...
Shenzhen’s LWPOCT Secures RMB 100 Million in Series A Round for CDMO Expansion
Shenzhen-based medical devices and reagents manufacturer Shenzhen Living Water POCT Co., LTd (LWPOCT) has reportedly...
Henlius Biotech Begins Global Phase III Trial for Denosumab Biosimilar HLX14
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced the first patient dosing in a...
Cellular Biomedicine Group’s C-CAR039 Receives NMPA Approval for B-Cell NHL Study
China-based Cellular Biomedicine Group Inc. (CBMG), a private company following a merger deal in February...
Global Cord Blood Corp’s Cellenkos Gets FDA Nod for Myelofibrosis Trial
Global Cord Blood Corporation (GCBC; NYSE: CO) announced receiving Investigational New Drug (IND) approval from...
Hangzhou Tongee Medical Closes RMB 100 Million Series B Round for Gastric Bypass Stent
Hangzhou Tongee Medical Technology Co., Ltd, a Chinese device maker specializing in metabolic disease treatments,...
Scotland Reports First Case of ASHep-UA in Children, WHO Issues Guidelines
Scotland recorded its first case of acute severe hepatitis of unknown etiology in children (ASHep-UA)...
Walvax’s mRNA Vaccine AWcorna Shows Superior Immune Response in Phase III Trial
Walvax Biotechnology Co., Ltd’s (SHE: 300142) mRNA vaccine against SARS-CoV-2, named AWcorna, has reached the...
Tianhe-2 Supercomputer Aids Drug Discovery with Deep-Learning Biosynthetic Tool
China’s Tianhe-2 supercomputer, ranked among the top-10 fastest computers globally, has demonstrated potential in enhancing...
Shanghai Pharmaceuticals Licenses Benapenem and Plazomicin from Xuanzhu Bio for Greater China
China-based pharmaceutical giant Shanghai Pharmaceuticals (HKG: 2607, SHA: 601607) announced a licensing agreement with compatriot...
Sichuan Meida’s Phentolamine Gains Priority Review for Pheochromocytoma Treatment
The Center for Drug Evaluation (CDE) website indicates that Sichuan Meida Kangjiale Pharmaceutical Co., Ltd’s...
Mabwell’s 6MW3511 Accepted by NMPA for Advanced Solid Tumor Treatment
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) announced that a clinical trial filing for...
NMPA Approves 164 Medical Devices in May 2022, Including Medtronic and Boston Scientific Products
The National Medical Products Administration (NMPA) approved a total of 164 medical devices for marketing...